These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
293 related items for PubMed ID: 9639729
1. [Estrogen and progesterone receptors in endometrial carcinoma]. Guo Y, Dang Q. Zhonghua Fu Chan Ke Za Zhi; 1997 Jul; 32(7):418-21. PubMed ID: 9639729 [Abstract] [Full Text] [Related]
2. [Study of estrogen and progesterone receptors in endometrial carcinoma]. Chen Y, Peng Z. Hua Xi Yi Ke Da Xue Xue Bao; 2000 Mar; 31(1):98-100. PubMed ID: 12501628 [Abstract] [Full Text] [Related]
3. Prognostic significance of progesterone receptor immunohistochemistry in endometrial carcinoma. Fukuda K, Mori M, Uchiyama M, Iwai K, Iwasaka T, Sugimori H. Gynecol Oncol; 1998 Jun; 69(3):220-5. PubMed ID: 9648591 [Abstract] [Full Text] [Related]
4. Expression of estrogen receptors alpha and beta, and progesterone receptors A and B in human mucinous carcinoma of the endometrium. Shabani N, Mylonas I, Jeschke U, Thaqi A, Kuhn C, Puchner T, Friese K. Anticancer Res; 2007 Jun; 27(4A):2027-33. PubMed ID: 17649817 [Abstract] [Full Text] [Related]
5. Simultaneous immunohistochemical and biochemical hormone receptor assessment in breast cancer provides complementary prognostic information. Biesterfeld S, Schröder W, Steinhagen G, Koch R, Veuskens U, Schmitz FJ, Handt S, Böcking A. Anticancer Res; 1997 Jun; 17(6D):4723-9. PubMed ID: 9494596 [Abstract] [Full Text] [Related]
6. Estrogen receptor status, determined by immunohistochemistry, as a predictor of the recurrence of stage I endometrial carcinoma. Gehrig PA, Van Le L, Olatidoye B, Geradts J. Cancer; 1999 Nov 15; 86(10):2083-9. PubMed ID: 10570435 [Abstract] [Full Text] [Related]
7. [Study on expression of PCNA and estrogen, progesterone receptors in endometrial carcinoma]. Chen YP, Shen M, Chen C. Hunan Yi Ke Da Xue Xue Bao; 2001 Apr 28; 26(2):123-5. PubMed ID: 12536641 [Abstract] [Full Text] [Related]
8. [Immunohistochemical study on estrogen receptors in conventionally formalin-fixed, paraffin-embedded tissues of endometrial carcinoma]. Zhang ZG, Xu MH, Wang MQ. Zhonghua Fu Chan Ke Za Zhi; 1994 Nov 28; 29(11):667-9, 699-700. PubMed ID: 7712889 [Abstract] [Full Text] [Related]
9. [Correlation between receptor status and results of treatment in endometrial carcinoma]. Baĭnazarova AA, Iskakova ZhK. Vopr Onkol; 2006 Nov 28; 52(6):654-8. PubMed ID: 17338243 [Abstract] [Full Text] [Related]
10. Epithelial and stromal estrogen and progesterone receptor expression in endometrial cancer: true color computer-assisted image analysis versus subjective scoring. Kohlberger PD, Kieback DG, Breitenecker F, Loesch A, Gitsch G, Kainz C, Breitenecker G. Gynecol Oncol; 1997 Mar 28; 64(3):404-10. PubMed ID: 9062141 [Abstract] [Full Text] [Related]
11. Prognostic value of estrogen receptor and progesterone receptor tumor expression in Danish ovarian cancer patients: from the 'MALOVA' ovarian cancer study. Høgdall EV, Christensen L, Høgdall CK, Blaakaer J, Gayther S, Jacobs IJ, Christensen IJ, Kjaer SK. Oncol Rep; 2007 Nov 28; 18(5):1051-9. PubMed ID: 17914554 [Abstract] [Full Text] [Related]
12. Prognostic significance of ER, PR, Ki67, c-erbB-2, and p53 in endometrial carcinoma. Suthipintawong C, Wejaranayang C, Vipupinyo C. J Med Assoc Thai; 2008 Dec 28; 91(12):1779-84. PubMed ID: 19133508 [Abstract] [Full Text] [Related]
13. [Measurement of estrogen receptor and progesterone receptor in human endometrium and endometrial carcinoma]. Itoh E. Nihon Gan Chiryo Gakkai Shi; 1990 Apr 20; 25(4):812-20. PubMed ID: 2196312 [Abstract] [Full Text] [Related]
14. Tamoxifen-associated malignant endometrial tumors: pathologic features and expression of hormone receptors estrogen-alpha, estrogen-beta and progesterone; a case controlled study. Wilder JL, Shajahan S, Khattar NH, Wilder DM, Yin J, Rushing RS, Beaven R, Kaetzel C, Ueland FR, van Nagell JR, Kryscio RJ, Lele SM. Gynecol Oncol; 2004 Feb 20; 92(2):553-8. PubMed ID: 14766247 [Abstract] [Full Text] [Related]
15. The expression analysis of the estrogen and progesterone receptors in endometrial carcinomas. Olech-Fudali E, Chibowski D, Skomra D, Walczyna B. Ann Univ Mariae Curie Sklodowska Med; 2001 Feb 20; 56():319-25. PubMed ID: 11977333 [Abstract] [Full Text] [Related]
16. Expression of cyclooxygenase-2 (COX-2), receptors for estrogen (ER), and progesterone (PR), p53, ki67, and neu protein in endometrial cancer. Ferrandina G, Ranelletti FO, Gallotta V, Martinelli E, Zannoni GF, Gessi M, Scambia G. Gynecol Oncol; 2005 Sep 20; 98(3):383-9. PubMed ID: 15979129 [Abstract] [Full Text] [Related]
17. [Microsatellite instability in endometrial neoplasms correlation with clinicopathologic parameters and estrogen receptor or progesterone receptor status]. Song Y, Lang J. Zhonghua Fu Chan Ke Za Zhi; 2000 May 20; 35(5):273-6. PubMed ID: 11775905 [Abstract] [Full Text] [Related]
18. [Expression of estrogen receptor and progesterone receptor in colorectal cancer: a quantitative study]. Zhou ZW, Wan DS, Wang GQ, Pan ZZ, Lu HP, Gao JH, Ding PR. Ai Zheng; 2004 Jul 20; 23(7):851-4. PubMed ID: 15248927 [Abstract] [Full Text] [Related]
19. [Estrogen and progesterone receptors in normal cervix and primary cervical carcinoma]. Shen K, Yueng W, Ngan H. Zhonghua Fu Chan Ke Za Zhi; 1994 May 20; 29(5):284-8, 317-8. PubMed ID: 7956553 [Abstract] [Full Text] [Related]
20. Estrogen and progesterone receptors in normal cervix and primary cervical carcinoma. Shen K, Yueng W, Ngan H. Chin Med J (Engl); 1994 Sep 20; 107(9):648-52. PubMed ID: 7805454 [Abstract] [Full Text] [Related] Page: [Next] [New Search]